NCT06232460

An Open Label, Dose-escalation Study, Assessing the Safety and Tolerability of a Collagen Peptide

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Rousselot BVBA · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

This study evaluates the safety and tolerability of three different doses (5 g, 10 g and 20 g) of a collagen powder in healthy adults over a 12-week period.

Detailed description

This study evaluates the safety and tolerability of three different doses (5 g, 10 g and 20 g) of a collagen powder, each for 4-weeks in healthy adults over a 12-week period by measuring occurrence of adverse events, safety blood panel, vital signs, occurrence of common gastrointestinal symptom's and the Gastrointestinal Symptom Rating Scale

Conditions

• Tolerance

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	H80	5g, 10g \& 20g

Timeline

• Start date: 2024-02-08
• Primary completion: 2024-07-29
• Completion: 2024-07-29
• First posted: 2024-01-30
• Last updated: 2025-05-09

Locations

1 site across 1 country: United States